Ra Capital Management as of Dec. 31, 2021
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 97 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A/s Sponsored (ASND) | 17.9 | $1.0B | 7.6M | 134.53 | |
| Novavax Com New (NVAX) | 5.3 | $300M | 2.1M | 143.07 | |
| Iteos Therapeutics (ITOS) | 3.6 | $206M | 4.4M | 46.56 | |
| Travere Therapeutics (TVTX) | 3.1 | $174M | 5.6M | 31.04 | |
| Janux Therapeutics (JANX) | 3.0 | $171M | 8.7M | 19.73 | |
| Cytek Biosciences (CTKB) | 2.8 | $157M | 9.6M | 16.32 | |
| ImmunoGen | 2.6 | $150M | 20M | 7.42 | |
| Eliem Therapeutics (ELYM) | 2.4 | $138M | 13M | 10.46 | |
| Icosavax | 2.3 | $132M | 5.8M | 22.88 | |
| Dice Therapeutics | 2.3 | $132M | 5.2M | 25.31 | |
| Vor Biopharma (VOR) | 2.3 | $129M | 11M | 11.62 | |
| Forma Therapeutics SHS | 2.3 | $128M | 9.0M | 14.22 | |
| Tyra Biosciences (TYRA) | 1.8 | $102M | 7.2M | 14.07 | |
| Vaxcyte (PCVX) | 1.8 | $101M | 4.2M | 23.79 | |
| Macrogenics (MGNX) | 1.7 | $98M | 6.1M | 16.05 | |
| Aerovate Therapeutics (AVTE) | 1.7 | $97M | 8.3M | 11.79 | |
| Nkarta (NKTX) | 1.5 | $86M | 5.6M | 15.35 | |
| Day One Biopharmaceuticals I (DAWN) | 1.5 | $84M | 5.0M | 16.85 | |
| Instil Bio | 1.5 | $83M | 4.9M | 17.11 | |
| Bellus Health Com New | 1.5 | $82M | 10M | 8.05 | |
| Celldex Therapeutics Com New (CLDX) | 1.2 | $70M | 1.8M | 38.64 | |
| Tenaya Therapeutics (TNYA) | 1.2 | $67M | 3.6M | 18.95 | |
| Gh Research Ordinary Shares (GHRS) | 1.2 | $66M | 2.8M | 23.33 | |
| Acumen Pharmaceuticals (ABOS) | 1.2 | $66M | 9.8M | 6.76 | |
| 89bio (ETNB) | 1.1 | $65M | 5.0M | 13.07 | |
| Kinnate Biopharma (KNTE) | 1.1 | $64M | 3.6M | 17.72 | |
| Phathom Pharmaceuticals (PHAT) | 1.1 | $61M | 3.1M | 19.67 | |
| Mirati Therapeutics | 1.0 | $56M | 381k | 146.69 | |
| Zogenix Com New | 1.0 | $54M | 3.3M | 16.25 | |
| Pardes Biosciences | 0.9 | $51M | 3.1M | 16.37 | |
| Werewolf Therapeutics (HOWL) | 0.9 | $51M | 4.3M | 11.91 | |
| Point Biopharma Global | 0.9 | $50M | 9.0M | 5.60 | |
| Rhythm Pharmaceuticals (RYTM) | 0.9 | $49M | 4.9M | 9.98 | |
| Lianbio Sponsored Ads (LIANY) | 0.8 | $47M | 7.7M | 6.16 | |
| Design Therapeutics (DSGN) | 0.8 | $47M | 2.2M | 21.41 | |
| Rocket Pharmaceuticals (RCKT) | 0.8 | $46M | 2.1M | 21.83 | |
| Relmada Therapeutics (RLMD) | 0.8 | $45M | 2.0M | 22.53 | |
| C4 Therapeutics Com Stk (CCCC) | 0.8 | $44M | 1.4M | 32.20 | |
| Tg Therapeutics (TGTX) | 0.7 | $42M | 2.2M | 19.00 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.7 | $41M | 3.4M | 12.24 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.7 | $40M | 3.6M | 11.26 | |
| Edgewise Therapeutics (EWTX) | 0.7 | $40M | 2.6M | 15.28 | |
| Pmv Pharmaceuticals (PMVP) | 0.7 | $40M | 1.7M | 23.10 | |
| Cyteir Therapeutics | 0.7 | $38M | 3.4M | 11.37 | |
| Geron Corporation (GERN) | 0.6 | $37M | 30M | 1.22 | |
| Adagio Therapeutics (IVVD) | 0.6 | $36M | 5.0M | 7.26 | |
| Connect Biopharma Hldgs Ads (CNTB) | 0.6 | $36M | 7.0M | 5.15 | |
| Rxsight (RXST) | 0.6 | $34M | 3.1M | 11.25 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.6 | $34M | 5.1M | 6.72 | |
| Graphite Bio | 0.6 | $34M | 2.7M | 12.43 | |
| Dyne Therapeutics (DYN) | 0.6 | $33M | 2.8M | 11.89 | |
| Xilio Therapeutics (XLO) | 0.6 | $32M | 2.0M | 16.00 | |
| Satsuma Pharmaceuticals Ord | 0.5 | $27M | 5.9M | 4.50 | |
| Kalvista Pharmaceuticals (KALV) | 0.5 | $26M | 1.9M | 13.23 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.4 | $25M | 5.0M | 5.01 | |
| Pyxis Oncology Common Stock (PYXS) | 0.4 | $25M | 2.3M | 10.97 | |
| Tango Therapeutics (TNGX) | 0.4 | $25M | 2.3M | 10.94 | |
| Wave Life Sciences SHS (WVE) | 0.4 | $24M | 7.8M | 3.14 | |
| Solid Biosciences | 0.4 | $22M | 12M | 1.75 | |
| Olema Pharmaceuticals (OLMA) | 0.4 | $20M | 2.2M | 9.36 | |
| Akouos | 0.3 | $19M | 2.3M | 8.50 | |
| Relay Therapeutics (RLAY) | 0.3 | $17M | 549k | 30.71 | |
| Chinook Therapeutics | 0.3 | $16M | 1.0M | 16.31 | |
| Synlogic | 0.3 | $16M | 6.7M | 2.42 | |
| Milestone Pharmaceuticals (MIST) | 0.3 | $15M | 2.2M | 6.55 | |
| Da32 Life Scnce Class A Com | 0.3 | $15M | 1.5M | 9.81 | |
| Century Therapeutics (IPSC) | 0.3 | $15M | 914k | 15.86 | |
| Larimar Therapeutics (LRMR) | 0.3 | $14M | 1.3M | 10.79 | |
| Black Diamond Therapeutics (BDTX) | 0.2 | $14M | 2.6M | 5.33 | |
| Scpharmaceuticals (SCPH) | 0.2 | $14M | 2.7M | 5.02 | |
| Kala Pharmaceuticals | 0.2 | $13M | 11M | 1.21 | |
| Orchard Therapeutics Ads | 0.2 | $13M | 9.7M | 1.32 | |
| Nautilus Biotechnology (NAUT) | 0.2 | $13M | 2.4M | 5.18 | |
| Bcls Acquisition Corp Com Cl A | 0.2 | $12M | 1.3M | 9.80 | |
| Io Biotech (IOBT) | 0.2 | $12M | 1.9M | 6.40 | |
| Bolt Biotherapeutics (BOLT) | 0.2 | $12M | 2.4M | 4.90 | |
| Otonomy | 0.2 | $12M | 5.6M | 2.08 | |
| Silverback Therapeutics (SPRY) | 0.2 | $12M | 1.7M | 6.66 | |
| Verve Therapeutics (VERV) | 0.2 | $11M | 310k | 36.87 | |
| Avidity Biosciences Ord (RNA) | 0.2 | $10M | 424k | 23.77 | |
| Cue Health (HLTH) | 0.2 | $10M | 750k | 13.41 | |
| Frazier Lifesciences Acqu Cl A Shs | 0.2 | $9.9M | 1.0M | 9.92 | |
| Arya Sciences Acquisitn Class A Ord Shs | 0.2 | $9.7M | 1.0M | 9.70 | |
| Concert Pharmaceuticals I equity | 0.2 | $9.6M | 3.0M | 3.15 | |
| Ikena Oncology (IKNA) | 0.2 | $9.4M | 750k | 12.54 | |
| Cogent Biosciences (COGT) | 0.2 | $8.8M | 1.0M | 8.58 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.1 | $7.4M | 2.9M | 2.61 | |
| 5 01 Acquisition Corp Com Cl | 0.1 | $7.4M | 750k | 9.85 | |
| Astria Therapeutics (ATXS) | 0.1 | $6.8M | 1.3M | 5.39 | |
| Entera Bio SHS (ENTX) | 0.1 | $6.6M | 2.4M | 2.82 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.1 | $6.3M | 625k | 10.08 | |
| Compass Therapeutics (CMPX) | 0.1 | $5.9M | 1.8M | 3.17 | |
| Tscan Therapeutics (TCRX) | 0.1 | $5.6M | 1.3M | 4.50 | |
| Cullinan Oncology (CGEM) | 0.1 | $5.4M | 350k | 15.43 | |
| Biomea Fusion (BMEA) | 0.1 | $3.7M | 500k | 7.45 | |
| CVRX (CVRX) | 0.1 | $3.4M | 275k | 12.23 | |
| Syros Pharmaceuticals | 0.1 | $2.9M | 900k | 3.26 |
